← Back to Clinical Trials
Recruiting NCT07532382

NCT07532382 Personalized Stories for Pediatric Kidney Recipients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07532382
Status Recruiting
Phase
Sponsor Paris Translational Research Center for Organ Transplantation
Condition Kidney Transplant
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2026-03-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 12 Years
Study Type OBSERVATIONAL
Interventions
AI-generated storyAI generated story

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2026-03-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pediatric kidney transplant recipients often face major psychosocial challenges that are difficult to address with existing tools. This study evaluates whether clinically supervised AI can generate personalized, age-adapted therapeutic stories for these children and their families.

Eligibility Criteria

Inclusion Criteria: * Age 5-12 years inclusive at enrolment. * Recipient of a kidney transplant. * Clinically stable at enrolment (no active rejection, acute infection, or current hospitalization for a graft-related complication). * Fluency in French or English. * Written informed consent from parent(s)/legal guardian(s); child assent when age-appropriate. Exclusion Criteria: * Severe cognitive impairment precluding engagement with narrative content. * Mental state not allowing participation. * Family unwilling or unable to commit to the study timeline and interview requirements.

Contact & Investigator

Central Contact

Marc Raynaud, PhD

✉ mrayna06@gmail.com

📞 +33613493009

Principal Investigator

Marc Raynaud, PhD

PRINCIPAL INVESTIGATOR

Paris Institute for Transplantation and Organ Regeneration

Frequently Asked Questions

Who can join the NCT07532382 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 12 Years, studying Kidney Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07532382 currently recruiting?

Yes, NCT07532382 is actively recruiting participants. Contact the research team at mrayna06@gmail.com for enrollment information.

Where is the NCT07532382 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT07532382 clinical trial?

NCT07532382 is sponsored by Paris Translational Research Center for Organ Transplantation. The principal investigator is Marc Raynaud, PhD at Paris Institute for Transplantation and Organ Regeneration. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology